FDA clears Scopio Labs digital cell morphology platform
Scopio Labs received FDA 510(k) clearance for its X100HT hematology digital cell morphology platform with peripheral blood smear review.
Link to full article
In the media
Back to news lobbyScopio Labs received FDA 510(k) clearance for its X100HT hematology digital cell morphology platform with peripheral blood smear review.
September 17, 2024
Beckman Coulter and Scopio Labs Add World’s First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership
We are thrilled to announce the expansion of our long-term partnership with Beckman Coulter Diagnostics to include a global distribution agreement of Scopio’s Full-Field Bone Marrow Aspirate™ (FF-BMA)...
Read more
July 25, 2024
Scopio Labs Secures $42 Million in Funding Led by Fortissimo Capital
New Funding to Accelerate Scopio Labs' Commercial Growth and Product Innovation in Full-Field Digital Cell Morphology
Read more
April 17, 2024
Scopio Labs Receives Groundbreaking FDA Clearance for First-Ever Digital Bone Marrow Aspirate Application
The company’s 3rd FDA clearance accelerates the shift to AI-powered digital hematopathology, enhancing diagnostic speed and patient care.
Read more
